Chennai-based start-up developing Covid-19 remedy, plans to test in US

Patent application filed in India, firm hopes to bring product out in three years

Chennai-based incubation centre for research, Bioneemtec India, has joined the effort to developing a compound to control the replication of Coronavirus in the body and eliminate Covid-19. The start-up has been working on developing molecules that have anti-HIV properties. As Covid-19 has similar activity, teh firm has started developing molecules targeting the disease as well.

The company has been conducting computer-based molecular docking tests and is planning to carry them out in a laboratory in the US, through an agreement. Initially, the compound it developed wasn't very effective in combating the virus, but when some modifications were made, it became